Carlson Capital L.P. 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-19 4:05 pm Sale | 2024-11-15 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 124,000 3.450% | -93,960 (-43.11%) | Filing |
| 2024-05-08 4:26 pm Purchase | 2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 217,960 9.120% | 144,280 (+195.82%) | Filing |
| 2023-02-09 4:30 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 73,680 5.100% | -14,080 (-16.04%) | Filing |
| 2022-11-28 4:17 pm Purchase | 2022-11-22 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 87,760 6.200% | 87,760 (New Position) | Filing |